|
|
|
|
2013 Sanford-Burnham Annual Symposium
35th Annual Sanford-Burnham Symposium
Epigenetics: Developments and Disease
October 24, 2013
8:30 a.m. – 4:00 p.m. PT
Estancia La Jolla Hotel
La Jolla, California
This year’s event is specifically focused on Epigenetics, a fundamental element in the regulatory network of gene expression. We aim to gather experts in the key areas of epigenetics, including DNA methylation, noncoding RNA, and chromatin modification. We’ll discuss how epigenetics is involved in human development and how activators or inhibitors of these processes can be used to treat human diseases such as immune deficiencies and cancer.
Speaker details to be announced
|
|
|
Program
Continental Breakfast - 8:00 a.m. - 8:30 a.m. |
|
Welcome - 8:30 a.m. - 8:35 a.m.
Kristiina Vuori, M.D., Ph.D.
President, Sanford-Burnham Medical Research Institute
Session 1: 8:40 a.m. - 10:20 a.m.
Moderator: Mark Mercola, Ph.D.
Disease Modeling and Drug Screening
New Ways to Use Stem Cells to Study Motor Neuron Diseases
Lee Rubin, Ph.D.
Director of Translational Medicine, Harvard Stem Cell Institute
Cardiomycoytes from Pluripotent Stem Cells in Disease Modeling and Drug Discovery
Christine Mummery, Ph.D.
Leiden University Medical Center, The Netherlands
A Drug-Screening Platform for Autism Using Human Neurons
Alysson Muotri, Ph.D.
Assistant Professor, Department of Pediatrics and Cellular and Molecular Medicine, UC San Diego
|
|
Coffee- 10:25 a.m. - 10:45 a.m. |
|
Session 2: 10:50 a.m. - 12:00 p.m.
Moderator: Michael Jackson, Ph.D.
Small Molecule Modulators of Stem Cell Differentiation and Regeneration
Development of a Pharmacological Approach to Myocardial Regeneration
Mark Mercola, Ph.D.
Professor, Sanford Children’s Health Research Center
Director, Muscle Development and Regeneration Program, Sanford-Burnham Medical Research Institute
Neurogenic Small Molecules for Brain Repair and Plasticity
Jenny Hsieh, Ph.D.
Principal Investigator, Dept. of Molecular Biology, UT Southwestern Medical School, Dallas
In Vivo Small Molecule Discovery
Randall Peterson, Ph.D.
Scientific Director, Cardiovascular Research Center, Massachusetts General Hospital
|
|
Lunch - 12:30 p.m. - 1:45 p.m. |
|
Session 3: 1:50 p.m. - 4:05 p.m.
Moderator: Evan Snyder, M.D., Ph.D.
Modeling Complex Disease Traits from iPSCs
Using Stem Cells to Understand and Treat Neurodegenerative Disease
Larry Goldstein, Ph.D.
Investigator, HHMI
Distinguished Professor, Dept of Cellular and Molecular Medicine
Director, Dept of Neurosciences, UC San Diego School of Medicine
Using iPSCs to Study Autism
Ricardo Dolmetsch, Ph.D.
Assistant Professor, Department of Neurobiology, Stanford University
Variability Between Human Pluripotent Stem Cells: Challenges and Opportunities
Ludovic Vallier, Ph.D.
Anne McLaren Laboratory for Regenerative Medicine, Cambridge
Modeling Huntington's Disease and Spinal Muscular Atrophy using iPS Cells
Clive Svendsen, Ph.D.
Director, Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles
Closing Remarks - 4:15 p.m.
Kristiina Vuori, M.D., Ph.D.
President, Sanford-Burnham Medical Research Institute
|
|
|
|
|
|